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of detected organisms (95% CI, 75.7, 100).
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1 or more co-infecting organisms (N=9) was

nearly always resistant to macrolide

Hospital and Clinics.

common among females with M. genitalium.

antibiotics. Additional work is needed to

We excluded samples that were taken for

(Figure 1)

clarify the potential pathogenic role of M.

Macrolide resistance was found in 3 of the 4

genitalium in adolescent female

females treated with Azithromycin.

reproductive health.

emergency departments, pediatric/adolescent

resistance rates in adolescent females.

clinics, and urgent care sites at Children’s Mercy

resistance among adolescent females

concerns of abuse or wards of state.

seeking care at a pediatric children’s hospital.
The secondary objective was to describe the
symptomatology, co-infections, prescribed
antibiotic treatment, socio-demographics,
and sexual risk behaviors.
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M. genitalium detection: Aptima Mycoplama
genitalium assay (Hologic)

•

M. genitalium was detected relatively
salvaged from adolescent females

related to its prevalence and macrolide

•
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Macrolide resistance was identified in 89.5%

females aged 12-17 years presenting to the

To determine the prevalence of M.

Prevalence of M. genitalium was 9.5% (95%

frequently among genitourinary samples

not well defined with knowledge gaps
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CI, 5.4, 13.6); Total N=19. Mean age 17 years.

(56 urine and 144 vaginal) from adolescent

genitalium and detected macrolide
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We collected 200 discarded urogenital samples

transmitted organism. Its pathogenic role is

Objective
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M. genitalium was more common in black

Macrolide resistance : Lightmix Modular

females than whites [OR 6.23 (95% CI, 1.37-

Mycoplasma Macrolide kit (TIB MOLBIOL)

28.36)].

•

Results confirmed by Sanger Sequencing.

•

We reviewed electronic medical records to
determine presenting symptoms, concurrent
urinary tract or sexually transmitted infections,
socio-demographics, and sexual behaviors.

Mycoplasma genitalium and co-infecting organisms
M. genitalium
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